Arginine Replacement Therapy in COVID-19

Recruiting

Phase 2

Arginine Replacement Therapy in COVID-19Arginine Replacement Therapy in COVID-19

Sponsor:

Emory University

Code:

NCT05855330

Conditions

COVID-19

Eligibility Criteria

Sex: All

Age: 3 - 21

Healthy Volunteers: Not accepted

Interventions

Arginine Hydrochloride

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-03-29. This information was provided to ClinicalTrials.gov by Emory University on 2024-02-28.